Levomilnacipran and Phenelzine Interaction

Drug interaction information between Levomilnacipran and Phenelzine.

Levomilnacipran and Phenelzine have a documented moderate interaction in FDA labeling.

FDA drug labeling documents a moderate-severity interaction between Levomilnacipran and Phenelzine. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Levomilnacipran

Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)

Drug B

Phenelzine

Monoamine Oxidase Inhibitor (MAOI)

How They Interact

Both drugs increase serotonin levels in the brain, which can lead to a dangerous buildup called serotonin syndrome.

FDA Label Information

Examples: selegiline, tranylcypromine, isocarboxazid, phenelzine, linezolid, methylene blue Other Serotonergic Drugs Clinical Impact: Concomitant use of FETZIMA with other serotonergic drugs increases the risk of serotonin syndrome.

Levomilnacipran Also Interacts With

View all Levomilnacipran interactions →

Phenelzine Also Interacts With

View all Phenelzine interactions →

Frequently Asked Questions

What SPL severity band is on file for Levomilnacipran + Phenelzine?

Compiled FDA labeling labels this pair moderate. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Phenelzine has 27 labeled pairs on file vs Levomilnacipran's 11. In the moderate band specifically: Levomilnacipran has 4 (also Linezolid, Tranylcypromine, Selegiline); Phenelzine has 11 (also Sertraline, Fluoxetine, Citalopram, Venlafaxine).

What mechanism field is on file for Levomilnacipran and Phenelzine?

Both drugs increase serotonin levels in the brain, which can lead to a dangerous buildup called serotonin syndrome.

Phenelzine's labeled portfolio outnumbers Levomilnacipran

SPL source-record counts only. This page's band is moderate · classes on file: Levomilnacipran (Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)); Phenelzine (Monoamine Oxidase Inhibitor (MAOI)).

Levomilnacipran

0 major · 4 moderate · 7 minor · 11 total

Phenelzine

0 major · 11 moderate · 16 minor · 27 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.